» Articles » PMID: 30505825

Long-term Outcomes After Stent Insertion in Patients with Early and Late Hepatic Vein Outflow Obstruction After Living Donor Liver Transplantation

Overview
Specialty General Surgery
Date 2018 Dec 4
PMID 30505825
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The purpose of this study was to describe the long-term effects of stenting in patients with hepatic venous outflow obstruction (HVOO), who underwent living donor liver transplantation (LDLT).

Methods: Between January 2000 and December 2009, 622 adult patients underwent LDLT at our hospital, and of these patients, 21 (3.3%) were diagnosed with HVOO; among these patients, 17 underwent stenting. The patients were divided into early or late groups according to the time of their HVOO diagnoses (cutoff: 60 days after liver transplantation).

Results: The median follow-up period was 54.2 months (range, 0.5-192.4 months). Stent insertion was successful in 8 of 10 patients in the early group and 6 of 7 in the late group. The 5-year primary patency rates were 46% and 20%, respectively. In both groups, patients with recurrent HVOO at the beginning showed kinking confirmed by venography. Patients who carried their stents for more than 3 years maintained long-term patency. There was no significant difference in spleen size between groups; however, when the groups were compared according to whether they maintained patency, spleens tended to be smaller in the patency-maintained group.

Conclusion: Unlike stenosis, if kinking is confirmed on venography, stenting is not feasible in the long term for patients with LDLT.

Citing Articles

Tolerogenic Role of Myeloid Suppressor Cells in Organ Transplantation.

Ochando J, Conde P, Utrero-Rico A, Paz-Artal E Front Immunol. 2019; 10:374.

PMID: 30894860 PMC: 6414442. DOI: 10.3389/fimmu.2019.00374.

References
1.
Adam R, Karam V, Delvart V, OGrady J, Mirza D, Klempnauer J . Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol. 2012; 57(3):675-88. DOI: 10.1016/j.jhep.2012.04.015. View

2.
Marrero J, Kulik L, Sirlin C, Zhu A, Finn R, Abecassis M . Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018; 68(2):723-750. DOI: 10.1002/hep.29913. View

3.
Ko G, Sung K, Yoon H, Kim K, Kim J, Gwon D . Early posttransplant hepatic venous outflow obstruction: Long-term efficacy of primary stent placement. Liver Transpl. 2008; 14(10):1505-11. DOI: 10.1002/lt.21560. View

4.
Cirera I, Navasa M, Rimola A, Garcia-Pagan J, Grande L, Garcia-Valdecasas J . Ascites after liver transplantation. Liver Transpl. 2000; 6(2):157-62. DOI: 10.1002/lt.500060219. View

5.
Chikamori F, Nishida S, Selvaggi G, Tryphonopoulos P, Moon J, Levi D . Effect of liver transplantation on spleen size, collateral veins, and platelet counts. World J Surg. 2009; 34(2):320-6. DOI: 10.1007/s00268-009-0314-x. View